Synthesis of silver-cerium titanate nanotubes and their surface properties and antibacterial applications.

Nano-heterostructures of titanate nanotubes were synthesized and they revealed a complex structure with the formation of TiO ₂ (anatase), CeO ₂ , Ag ₂ O and metallic silver nanoparticles on the outer walls and intercalation of Ce ⁴⁺ and Ag ⁺ into the interlayer spaces of the nanotubes by microwave-assisted hydrothermal process and subjected to ion exchange reactions. To the best of our knowledge, this is the first reported silver and cerium co-exchanged titanate nanotubes for bio-applications. The co-ion exchange processes preserved the original tubular structure of titanate nanotubes with significant changes of the superficial as well as interlamellar environment. This study opens up possibility of synthesizing complex, functional nano-heterostructure with the scope of modification of the final structure, especially the amount and oxidation state of the intercalated cation (Ce ⁴⁺ , Ce ³⁺ and Ag ⁺ ) as well as the quantity and variety of the decorating nanoparticles (CeO ₂ , Ag ₂ O or metallic Ag). The interplay of which, in turn, can lead to important biological properties and applications, owing to their ion-liberation capacity. The samples were tested in antibacterial activity with two different kind of bacteria (gram positive and negative), cell cytotoxicity and adhesion, and it was found that the nano-heterostructure formed shows high antibacterial activity with low cytotoxicity and high cell adhesion, which makes it a promising material for further health applications.
Competing Interests: Declaration of competing interest On behalf of the authors of the article “Synthesis of Silver-Cerium Titanate Nanotubes and their surface properties and antibacterial applications”, I certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
(Copyright © 2020 Elsevier B.V. All rights reserved.)